VYGR Shares Outstanding History
Below is a table of the VYGR shares outstanding history going back to 11/11/2015:

Date VYGR Shares Outstanding
11/11/201525.72M
12/15/201526.75M
3/14/201626.75M
5/6/201626.75M
8/5/201626.73M
11/7/201626.72M
3/10/201726.85M
5/5/201726.85M
8/4/201726.90M
10/30/201726.95M
3/9/201832.21M
5/4/201832.32M
8/3/201832.44M
11/2/201832.56M
2/22/201932.62M
5/3/201936.83M
8/2/201936.93M
11/1/201937.07M
2/28/202037.15M
5/1/202037.19M
8/5/202037.43M
11/4/202037.47M
2/19/202137.65M
5/5/202137.73M
8/4/202137.94M
10/28/202137.96M
3/2/202238.11M
4/29/202238.46M

Also see: VYGR Market Cap History
VYGR YTD Return
VYGR Historical Shares Outstanding:
+6.42% CAGR
VYGR Historical Shares Outstanding: +6.42% CAGR

Mouse over chart for data details
11/11/2015 ...4/29/2022
Voyager Therapeutics is a gene therapy company focused on developing treatments and platform technologies. Co.'s team has developed a proprietary adeno-associated virus (AAV) capsid discovery platform called TRACER™ (Tropism Redirection of AAV by Cell Type-Specific Expression of RNA) to facilitate the selection of AAV capsids with blood brain barrier crossing and cell-specific transduction properties for particular therapeutic applications. The TRACER discovery platform is a functional RNA-based AAV capsid discovery platform that allows for rapid in vivo evolution of AAV capsids with cell-specific transduction properties in multiple species, including non-human primates. We show 28 historical shares outstanding datapoints in our coverage of VYGR's shares outstanding history.

Understanding the changing numbers of VYGR shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like VYGR versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching VYGR by allowing them to research VYGR shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree VYGR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Voyager Therapeutics (VYGR) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

VYNE Shares Outstanding History
VYNT Shares Outstanding History
WAT Shares Outstanding History
WCG Shares Outstanding History
WINT Shares Outstanding History
WMGI Shares Outstanding History
XAIR Shares Outstanding History
XBIO Shares Outstanding History
XCUR Shares Outstanding History
XENT Shares Outstanding History
More Healthcare companies »

 

VYGR Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.